
Krka Investor Relations Material
Latest events

Q1 2024
Krka

Q2 2025
24 Jul, 2025

Q1 2025
16 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Krka d. d.
Access all reports
Krka, d. d., Novo mesto is a Slovenia-based international generic pharmaceutical company. The company focuses on the development, production, marketing, and sales of pharmaceutical products for human health, including prescription pharmaceuticals, self-medication products, and cosmetics. Additionally, Krka extends its product range to animal health products. With a presence in more than 70 countries, Krka has established production and distribution centers in key markets such as Russia, Poland, Croatia, and Germany, supporting its global distribution network. The company's commitment to quality and innovation has been instrumental in its expansion and ability to meet diverse health needs worldwide. The company is headquartered in Novo Mesto, Slovenia, and its shares are listed on the Warsaw Stock Exchange.
Key slides for Krka d. d.


Q4 2024
Krka d. d.


Q2 2025
Krka d. d.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
KRK
Country
🇸🇮 Slovenia